Neurodegenerative Disease Clinical Trials

4 recruiting

Frequently Asked Questions

Common questions about Neurodegenerative Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 30 trials

Recruiting
Phase 2

Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease

Alzheimer DementiaLate Onset Alzheimer DiseaseNeurodegenerative Diseases
University of Arizona100 enrolled10 locationsNCT04838301
Recruiting
Phase 3

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

DementiaBrain DiseasesCentral Nervous System Diseases+6 more
Eli Lilly and Company1,500 enrolled141 locationsNCT05508789
Recruiting
Not Applicable

Feasibility of Wearables in Dementia Care in Rural Taiwan

Circadian RhythmAlzheimer's DementiaNeuropsychiatric Symptoms Related to Neurodegenerative Disease+2 more
China Medical University Hospital20 enrolled1 locationNCT07249918
Recruiting
Not Applicable

Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity

Brain DiseasesCentral Nervous System DiseasesParkinson Disease+7 more
University Hospital, Bonn130 enrolled1 locationNCT07324330
Recruiting
Not Applicable

Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles.

ObesityMetabolic SyndromeInflammation+5 more
University of Seville8 enrolled1 locationNCT07361887
Recruiting

[18F]NIDF PET Imaging in Tau-related Diseases

Alzheimer s DiseaseTauopathiesNeurodegenerative Disease
Tianjin Medical University20 enrolled2 locationsNCT07306598
Recruiting
Not Applicable

Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia

DementiaAlzheimer DiseaseCommunication Disorders+11 more
University of Texas at Austin60 enrolled3 locationsNCT05741853
Recruiting

Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside

Cognitive ImpairmentDementiaCognitive Dysfunction+7 more
Mclean Hospital40 enrolled1 locationNCT05245903
Recruiting

Serotonin Release in Premotor and Motor PD

Parkinson DiseasePositron Emission TomographyNeurodegenerative Diseases+3 more
University of Exeter42 enrolled1 locationNCT05516732
Recruiting

Molecular Imaging of Inflammation in Parkinson's Disease Using LPS and TSPO-PET/MR

Parkinson DiseaseNeurodegenerative DiseasesREM Sleep Behavior Disorder (iRBD)
University of Exeter30 enrolled1 locationNCT05205291
Recruiting

Longitudinal Investigation of I2BS in PD

Parkinson DiseasePositron Emission TomographyNeurodegenerative Diseases+3 more
University of Exeter44 enrolled1 locationNCT05516719
Recruiting

Molecular and Functional Imaging in Monogenic PD.

Parkinson DiseaseNeurodegenerative DiseasesNervous System Disorder+2 more
University of Exeter45 enrolled1 locationNCT05518617
Recruiting
Not Applicable

Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia

DementiaBrain DiseasesCentral Nervous System Diseases+5 more
Advanced Technology & Communications158 enrolled11 locationsNCT06088121
Recruiting
Phase 4

Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases

Parkinson DiseaseNeurodegenerative DiseasesParkinson Disease Psychosis
Vanderbilt University Medical Center75 enrolled1 locationNCT05357612
Recruiting

Memory Deterioration in Alzheimer Disease

Magnetic Resonance ImagingAlzheimer DiseaseMemory Impairment+1 more
Norwegian University of Science and Technology30 enrolled1 locationNCT07118137
Recruiting

Saliva and Extracellular Vesicles for Neurodegenerative Diseases

Alzheimer DiseaseParkinson DiseaseMild Cognitive Impairment (MCI)+3 more
Fondazione Don Carlo Gnocchi Onlus242 enrolled5 locationsNCT06869135
Recruiting

Beta Amyloid PET/CT in Various Aβ-Related Disease

Beta-AmyloidNeurodegenerative DiseasesAmyloid
Tianjin Medical University500 enrolled3 locationsNCT06725706
Recruiting
Not Applicable

Neurologic Stem Cell Treatment Study

Cognitive ImpairmentDementiaTraumatic Brain Injury+23 more
MD Stem Cells500 enrolled3 locationsNCT02795052
Recruiting

Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis

DementiaNeurodegenerative Diseases
Monash University1,000 enrolled2 locationsNCT06339190
Recruiting
Not Applicable

Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands

Brain DiseasesCentral Nervous System DiseasesParkinson Disease+8 more
Radboud University Medical Center110 enrolled1 locationNCT06193252